Tonix Pharmaceuticals Stock Price - TNXP

0.025 (3.85%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.025 3.85% 0.675 0.635 0.712 0.65 0.65 15:51:15
Bid Price Ask Price Spread Spread % News
0.6751 0.6799 0.0049 0.72% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
20,691 18,826,667 $ 0.6787343 $ 12,778,305 4,775,246 0.3902 - 17.90
Last Trade Time Type Quantity Stock Price Currency
15:51:15 700 $ 0.675 USD

Tonix Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 35.93M 52.53M 49.13M $ - $ - -23.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 13.00 6.90%

more financials information »

Tonix Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TNXP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.6610.750.63050.65574175,281,3720.0142.12%
1 Month0.70260.8020.63050.68829435,329,396-0.0276-3.93%
3 Months0.70371.390.500.77786345,672,251-0.0287-4.08%
6 Months1.152.650.39021.016,721,406-0.475-41.3%
1 Year16.9017.900.39021.283,627,907-16.23-96.01%
3 Years435.00511.000.390222.471,604,854-434.33-99.84%
5 Years7,850.0010,720.000.3902348.141,245,699-7,849.33-99.99%

Tonix Pharmaceuticals Description

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is engaged in discovering, licensing, acquiring and developing drugs and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes biologics to prevent infectious diseases and small molecules and biologics to treat pain, psychiatric and addiction conditions. While the company is also developing a potential vaccine to protect against the novel coronavirus disease.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.